Reversal of neuromuscular blockade in humans by neostigmine and edrophonium: a mathematical model.
Generalizations of the integrated model describing the interaction of nondepolarizing neuromuscular blocking drugs with reversible anticholinesterase drugs described in Unadkat et al. (1) are reported. The models can deal with possible incomplete reversal (irreversible block) and/or noninstantaneous anticholinesterase kinetics. Experimental data were obtained from 22 human volunteers. Different levels of steady-state vecuronium block were induced in each volunteer (in the range of 50% to 95%), and reversed by short infusions of edrophonium (10 volunteers) or neostigmine (12 volunteers). Edrophonium or neostigmine concentrations and twitch tension (measured as the force of thumb adduction) were measured. The generalized integrated models fit the data well. In the case of neostigmine we find a nondistributional delay in its action. We relate this delay to the slow decarbamylation rate of the (neostigmine-induced) carbamylated anticholinesterase observed in vitro, and are able to model such noninstantaneous anticholinesterase kinetic processes. For both edrophonium and neostigmine we detect an inverse relationship between the (induced) level of initial block and maximal percentage recovery.
Department of Pharmacy, School of Pharmacy, University of California San Francisco 94143.
D
D
Verotta
J
J
Kitts
R
R
Rodriguez
J
J
Coldwell
R D
RD
Miller
L B
LB
Sheiner
D000328:Adult; D004491:Edrophonium / Q000494:pharmacology*; D006801:Humans; D008433:Mathematics; D008875:Middle Aged; D008954:Models, Biological; D009388:Neostigmine / Q000494:pharmacology*; D014673:Vecuronium Bromide / Q000037:antagonists & inhibitors*
D009388:Neostigmine; D004491:Edrophonium; D014673:Vecuronium Bromide